Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordsschizophrenia・bipolar disorder・early psychosis・pharmacogenomics・treatment resistance・biomarkers・exosomal microRNA・sleep medicine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yoshikawa A*, Li J, Meltzer HY. Genetic markers of early response to lurasidone in acute schizophrenia. The Pharmacogenomics Journal, 25(2): 3. 2025.2025
• Fujimura, T, Yoshikawa A (他13名, 番目), Kato T. Factors associated with self-perceived treatment-resistance in bipolar disorder. Medicine 103(1):e36217, 2024.2024
• Yoshikawa A*, Obata Y, Kakiuchi C, Nakanishi A, Kimura S, Aoki S, Kato T. Case series of patients with early psychosis presenting hypoperfusion in angular gyrus and self-disturbance - implication for the sense of agency and schizophrenia. Neuropsychopharmacology Reports, 2024,00:1–10. 2024.2024
• Katsuta N, Takahashi K, Kurosawa Y, Yoshikawa A, Takeshita Y, Uchida Y, Yasuda S, Kakiuchi C, Ito M, Kato T. Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia. Sleep medicine: X 5 100070-100070 20232023

• Official profile